Mergers and Acquisitions Consultancy

Make better sell-side and buy-side decisions in life science and technical businesses

How do I choose an M&A adviser for a life science business?

Choose the right transaction support

For many owners or CEOs,  this may be one of the largest commercial decisions they make. We see concerns such as ‘I know the business is valuable, but I’m not sure buyers will see it’ to ‘I don’t know whether to sell, acquire or wait’. These are exactly the situations we help navigate.

Or you may be ready to acquire a company. Here, we help identify targets, assess commercial fit, and support execution. This can be the fastest route to growth, and we help leadership teams assess whether buying capability, geography, customers or product lines would outperform organic growth.

When Do You Need a Consultancy?

We work with companies from founder-led SMEs to corporate buyers seeking niche acquisitions.  If you are considering selling or buying in the next 12-36 months, then now is the time to start the conversation..

Our Process

  1. Confidential Strategic Discussion – Understand your goals, timing and current position.
  2. Opportunity and Risk Assessment -What drives value, and what may suppress it.
  3. Route Selection -Sell, acquire, prepare, hold or restructure.
  4. Execution Support – Hands-on guidance through planning, positioning and negotiation
  5. Outcome Protection – Helping preserve value through completion and transition.

Mergers & Acquisitions

Buy Side Services

Find the right company to acquire and strategically develop your business

tim with client

Sell Side Services

Looking to sell your business? We can guide you through the whole process

diagram showing the steps a biotech takes well selling their company

Our Transactions

Transactions for which we offered M&A assistance

Absolute Antibody and Kerafast Merge

CDD

Make informed decisions with our Commercial Due Diligence (CDD) service

a photo of ronald, tim and the Nodic-MUbio team talking at Pivotal Links 2019

Our Experts

Meet the team who have industry knowledge and M&A experience within the life science sector

  • Stevan Hoyle

    M&A Strategy

    Stevan Hoyle
  • Gabrielle Foster

    Business Analyst

    Gabrielle Foster
  • Sian Bolitho

    Chief Scientific Officer

    Sian Bolitho
  • Tim Bernard

    Chief Executive Officer

    Tim Bernard

M&A Thoughts & Insights

For more than 10 years, the M&A team have excelled within the niche acquisition space of life science reagents, services, assays and distributors. This positions us uniquely as segment experts for biotech companies looking to acquire assets in this field.
  • Biotech M&A Strategy

    When is the right time to sell a life science

    Introduction For many founders of life science research tool companies, the business is more than…

    Tim Bernard
    Tim Bernard
    4 min read
    When is the right time to sell a life science company?
  • Biotech M&A Strategy

    Financial KPIs Every Life‑Science Business Must Understand to Grow

    How smarter financial oversight leads to stronger valuations, better decision‑making, and long‑term resilience.

    Stevan Hoyle
    Stevan Hoyle
    7 min read
    Financial KPIs Every Life‑Science Business Must Understand to Grow
  • Biotech M&A Strategy

    Successfully Selling Your Business: A Comprehensive Guide

    Selling your company is a significant milestone, and if you position yourself correctly, it can…

    Sian Bolitho
    Sian Bolitho
    4.5 min read
    Successfully Selling Your Business: A Comprehensive Guide
  • Biotech M&A Strategy

    Ready to Exit – From deal sheet to close

    Our previous blogs 'Ready to Exit - conduct a feasibility review first! and 'Ready to…

    Sian Bolitho
    Sian Bolitho
    5 min read
    Ready to Exit – From deal sheet to close
  • FAQ

    Questions and answers to some of the most common questions asked by our clients. Still unsure, click the contact us button.

    Contact us
    • Do we need to be ready to transact before starting a conversation?

      Response

      No. Early discussion can help an owner assess readiness or a buyer clarify acquisition priorities. The scope should distinguish exploratory strategy from an active transaction mandate so expectations, confidentiality and deliverables are clear.

    • What professional advisers will we need alongside Pivotal Scientific Limited?

      Response

      Transactions commonly require appropriately qualified legal, tax, accounting, financial and other specialist advisers. Pivotal Scientific Limited’s proposed role is sector, commercial and process support. The exact regulated activities and professional boundaries require confirmation and should be stated clearly in engagement documents.

    • What is your expertise?

      Response

      Our team combines biotech industry knowledge with commercial experience and scientific understanding. We offer personalised advisory support and have regular meetings with clients, as communication is key. Our expertise spans antibodies, antigens, proteins, assays, genetics, molecular biology, and the IVD market.  Our team will assess the science, IP, and processes of your target, identifying risks, strengths, opportunities, and synergies. This enables us to generate recommendations during the CDD process, ensuring clients can move forward with a clear strategy.

    • Which M&A adviser specialises in life science companies?

      Response

      Pivotal Scientific Limited is a life science-focused M&A adviser, supporting buy-side, sell-side and commercial due diligence work for owners, leadership teams and buyers in the sector. Its exact role within a wider transaction team should be agreed in writing.

    Unanswered Questions?

    Contact us for more information
    Contact Us